Uncoating of Human Immunodeficiency Virus Type 1 Requires Prolyl Isomerase Pin1*
暂无分享,去创建一个
Naoki Kishimoto | N. Kishimoto | S. Misumi | N. Takamune | S. Shoji | Shogo Misumi | Nobutoki Takamune | Shozo Shoji | Mutsumi Inoue | Takeo Dochi | Naomi Hasegawa | T. Dochi | M. Inoue | N. Hasegawa
[1] P. O’Farrell. High resolution two-dimensional electrophoresis of proteins. , 1975, The Journal of biological chemistry.
[2] J. Burns,et al. A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[3] W. Sundquist,et al. Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. , 1997, Science.
[4] T. Hunter,et al. A human peptidyl–prolyl isomerase essential for regulation of mitosis , 1996, Nature.
[5] L. Montagnier,et al. Cell surface expression of several species of human immunodeficiency virus type 1 major core protein , 1989, Journal of virology.
[6] D. Forbes,et al. Differential Mitotic Phosphorylation of Proteins of the Nuclear Pore Complex (*) , 1995, The Journal of Biological Chemistry.
[7] T. Masuda,et al. Evaluation of the Functional Involvement of Human Immunodeficiency Virus Type 1 Integrase in Nuclear Import of Viral cDNA during Acute Infection , 2004, Journal of Virology.
[8] E. Lillehoj,et al. The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors , 1988, Journal of virology.
[9] S. Goff. Intracellular trafficking of retroviral genomes during the early phase of infection: viral exploitation of cellular pathways , 2001, The journal of gene medicine.
[10] T. Copeland,et al. Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24 , 1988, Journal of virology.
[11] K. Lu,et al. Phosphorylation-specific prolyl isomerization: is there an underlying theme? , 2005, Nature Cell Biology.
[12] Joseph Sodroski,et al. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[13] Masafumi Nakamura,et al. Pin1 regulates turnover and subcellular localization of β-catenin by inhibiting its interaction with APC , 2001, Nature Cell Biology.
[14] Jerome A. Zack,et al. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure , 1990, Cell.
[15] J. Kira,et al. Mutational analysis of human immunodeficiency virus type 1 (HIV-1) accessory genes: requirement of a site in the nef gene for HIV-1 replication in activated CD4+ T cells in vitro and in vivo , 1997, Journal of virology.
[16] M. Malim,et al. Intracellular trafficking of HIV-1 cores: journey to the center of the cell. , 2003, Current topics in microbiology and immunology.
[17] Tony Hunter,et al. Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration , 2003, Nature.
[18] P. Puthavathana,et al. Uncoating of HIV-1 requires cellular activation. , 2005, Virology.
[19] M. Kirschner,et al. The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins. , 1998, Genes & development.
[20] R. Wozniak,et al. Cell cycle-dependent phosphorylation of nucleoporins and nuclear pore membrane protein Gp210. , 1996, Biochemistry.
[21] S. Misumi,et al. Three Isoforms of Cyclophilin A Associated with Human Immunodeficiency Virus Type 1 Were Found by Proteomics by Using Two-Dimensional Gel Electrophoresis and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry , 2002, Journal of Virology.
[22] W. Sundquist,et al. Crystal Structure of Human Cyclophilin A Bound to the Amino-Terminal Domain of HIV-1 Capsid , 1996, Cell.
[23] S. Oka,et al. Rapid and Simple Phenotypic Assay for Drug Susceptibility of Human Immunodeficiency Virus Type 1 Using CCR5-Expressing HeLa/CD4+ Cell Clone 1-10 (MAGIC-5) , 2001, Antimicrobial Agents and Chemotherapy.
[24] H. Gendelman,et al. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone , 1986, Journal of virology.
[25] G. Blobel,et al. Cell-cycle-dependent phosphorylation of the nuclear pore Nup107–160 subcomplex , 2007, Proceedings of the National Academy of Sciences.
[26] Wesley I. Sundquist,et al. Structure of the Amino-Terminal Core Domain of the HIV-1 Capsid Protein , 1996, Science.
[27] S. Volinia,et al. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults , 2002, Nature.
[28] L. Arthur,et al. Cytoskeletal proteins inside human immunodeficiency virus type 1 virions , 1996, Journal of virology.
[29] S. Misumi,et al. Acid-labile formylation of amino terminal proline of human immunodeficiency virus type 1 p24(gag) was found by proteomics using two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry. , 2002, Biochemical and biophysical research communications.
[30] D. Harrich,et al. Cell Factors Stimulate Human Immunodeficiency Virus Type 1 Reverse Transcription In Vitro , 2007, Journal of Virology.
[31] M. Stevenson,et al. HIV‐1 replication is controlled at the level of T cell activation and proviral integration. , 1990, The EMBO journal.